Form 4 Forte Biosciences Inc For: 17 June
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Forte Biosciences Inc (FBRX)
Track today's live Forte Biosciences Inc (FBRX) share price, performance and key data on this page with our current NASDAQ:FBRX stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Forte Biosciences Inc share price on the NASDAQ exchange. Use the dropdown to switch exchange for the FBRX share price, head to our technical summary section, which provides analysis on Forte Biosciences Inc share price buy/sell indicators using real-time data (or discuss the Forte Biosciences Inc (FBRX) stock price today with other investors in the Forte Biosciences Inc NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:FBRX share price (ISIN: US34962G2084) to enhance your trading decisions with our free investment tools and resources.
What Is the Forte Biosciences Inc Share Price Today?
The Forte Biosciences Inc share price today is 19.2750.
What Is the Stock Symbol for Forte Biosciences Inc
The stock symbol (or 'ticker') for Forte Biosciences Inc is "FBRX."
What Stock Exchange Does Forte Biosciences Inc Trade On?
Forte Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Forte Biosciences Inc a Good Stock to Buy?
Determining whether Forte Biosciences Inc (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:FBRX share price (ISIN: US34962G2084) to enhance your trading decisions with our free investment tools and resources.
What Is the Forte Biosciences Inc Share Price Today?
The Forte Biosciences Inc share price today is 19.2750.
What Is the Stock Symbol for Forte Biosciences Inc
The stock symbol (or 'ticker') for Forte Biosciences Inc is "FBRX."
What Stock Exchange Does Forte Biosciences Inc Trade On?
Forte Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Forte Biosciences Inc a Good Stock to Buy?
Determining whether Forte Biosciences Inc (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
19.2750
+0.5650(+3.02%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.4050
20.2900
52 wk Range
9.1000
35.7999
FBRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.405020.2900
52 wk Range
9.100035.7999
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
FBRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
63.7500
Upside
+230.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 8K Forte Biosciences Inc For: 14 May
- Investing.com
- Form 13G Forte Biosciences For: 8 June
- Investing.com
- Form 10Q Forte Biosciences Inc For: 11 May
- Investing.com
- Form S-3/A Forte Biosciences Inc For: 8 June
- Investing.com
- Form 4 Forte Biosciences Inc For: 17 June
- Investing.com
- Form 13G Forte Biosciences For: 8 June
- Investing.com
- Form S-3/A Forte Biosciences Inc For: 8 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 63.7500
(+230.74% Upside)
Earnings
Latest Release
11/05/2026
EPS / Forecast
-1.24 / -1.21
Revenue / Forecast
-- / --
Compare FBRX to Peers and Sector
Metrics to compare | FBRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFBRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.5x | −5.4x | −0.4x | |
PEG Ratio | −0.14 | −0.03 | 0.00 | |
Price/Book | 11.7x | 3.8x | 2.6x | |
Price / LTM Sales | - | 20.9x | 3.0x | |
Upside (Analyst Target) | 236.7% | 87.9% | 56.2% | |
Fair Value Upside | Unlock | −5.7% | 8.9% | Unlock |
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Forte Biosciences Inc (NASDAQ: FBRX) Share Price Today?
The Forte Biosciences Inc stock price today is 19.2750 USD.
What Stock Exchange Does Forte Biosciences Inc (FBRX) Trade On?
Forte Biosciences Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Forte Biosciences Inc?
The stock symbol (also called a 'ticker') for Forte Biosciences Inc is "FBRX."
What Is the Current Forte Biosciences Inc Market Capitalisation?
As of today, Forte Biosciences Inc (NASDAQ: FBRX) market cap is 471.0000M USD.
What Is Forte Biosciences Inc's (FBRX) Earnings Per Share (TTM)?
The Forte Biosciences Inc EPS is currently -4.6459 (Trailing Twelve Months).
When Is the Next Forte Biosciences Inc Earnings Date?
Forte Biosciences Inc's next earnings report will be released on 17/08/2026.
Is FBRX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Forte Biosciences Inc moving averages and other technical indicators, the daily buy/sell signal for FBRX stock is Buy.
How Many Times Has Forte Biosciences Inc Stock Split?
Forte Biosciences Inc has split 2 times. (See the FBRX stock split history page for full effective split date and price information.)
How Many Employees Does Forte Biosciences Inc Have?
Forte Biosciences Inc has 22 employees, based on their latest Companies House report.
What is the current trading status of Forte Biosciences Inc (NASDAQ: FBRX)?
As of 26/06/2026, Forte Biosciences Inc (FBRX) is trading at a share price of 19.2750 USD, with a previous close of 18.7100 USD. The stock has fluctuated within a day range of 18.4050 USD to 20.2900 USD, while its 52-week range spans from 9.1000 USD to 35.7999 USD.
What Is Forte Biosciences Inc (FBRX) Price Target According to Analysts?
The average 12-month price target for Forte Biosciences Inc is 63.7500 USD, with a high estimate of 75 USD and a low estimate of 54 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +230.74% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.